These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. Ferrucci R; Cuffaro L; Capozza A; Rosci C; Maiorana N; Groppo E; Reitano MR; Poletti B; Ticozzi N; Tagliabue L; Silani V; Priori A J Neurol; 2023 Apr; 270(4):1823-1834. PubMed ID: 36692636 [TBL] [Abstract][Full Text] [Related]
5. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Rau A; Schroeter N; Blazhenets G; Dressing A; Walter LI; Kellner E; Bormann T; Mast H; Wagner D; Urbach H; Weiller C; Meyer PT; Reisert M; Hosp JA Brain; 2022 Sep; 145(9):3203-3213. PubMed ID: 35675908 [TBL] [Abstract][Full Text] [Related]
6. Metabolic correlates of cognitive impairment in mesial temporal lobe epilepsy. Laurent A; Artiges E; Mellerio C; Boutin-Watine M; Landré E; Semah F; Chassoux F Epilepsy Behav; 2020 Apr; 105():106948. PubMed ID: 32062107 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease]. Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030 [TBL] [Abstract][Full Text] [Related]
8. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642 [TBL] [Abstract][Full Text] [Related]
9. Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment. Eguchi A; Kimura N; Aso Y; Yabuuchi K; Ishibashi M; Hori D; Sasaki Y; Nakamichi A; Uesugi S; Jikumaru M; Sumi K; Shimomura T; Matsubara E Curr Alzheimer Res; 2019; 16(9):852-860. PubMed ID: 31385770 [TBL] [Abstract][Full Text] [Related]
10. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results. Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062 [TBL] [Abstract][Full Text] [Related]
11. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study. Tondo G; Boccalini C; Caminiti SP; Presotto L; Filippi M; Magnani G; Frisoni GB; Iannaccone S; Perani D J Alzheimers Dis; 2021; 80(1):433-445. PubMed ID: 33579848 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858 [TBL] [Abstract][Full Text] [Related]
13. Montreal Cognitive Assessment score correlates with regional cerebral blood flow in post-stroke patients. Nakaoku Y; Oishi N; Hase Y; Hase M; Saito S; Mitsueda T; Matsui M; Toyoda K; Nagatsuka K; Kalaria RN; Fukuyama H; Ihara M; Takahashi R Clin Neurol Neurosurg; 2018 Nov; 174():68-74. PubMed ID: 30216810 [TBL] [Abstract][Full Text] [Related]
14. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381 [TBL] [Abstract][Full Text] [Related]
15. Reduced Cortical Thickness Correlates of Cognitive Dysfunction in Post-COVID-19 Condition: Insights from a Long-Term Follow-up. Dacosta-Aguayo R; Puig J; Lamonja-Vicente N; Carmona-Cervelló M; León-Gómez BB; Monté-Rubio G; López-Linfante VM; Zamora-Putin V; Montero-Alia P; Chacon C; Bielsa J; Moreno-Gabriel E; Garcia-Sierra R; Pachón A; Costa A; Mataró M; Prado JG; Martinez-Cáceres E; Mateu L; Massanella M; Violán C; Torán-Monserrat P; AJNR Am J Neuroradiol; 2024 May; 45(5):647-654. PubMed ID: 38575319 [TBL] [Abstract][Full Text] [Related]
16. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease. Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596 [TBL] [Abstract][Full Text] [Related]
17. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment. Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728 [TBL] [Abstract][Full Text] [Related]
18. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
19. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function. Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467 [TBL] [Abstract][Full Text] [Related]